Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06182319 · ClinicalTrials.gov registry record · Phase 3
Optimizing Treatment of Adhesive Small Bowel Obstruction
A Phase 3 study of Adhesive Small Bowel Obstruction, sponsored by University of California, Los Angeles.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT06182319 is a Phase 3 study of Adhesive Small Bowel Obstruction that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 40 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06182319, a Phase 3 study of Adhesive Small Bowel Obstruction, is actively recruiting participants, sponsored by University of California, Los Angeles.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
Small bowel obstruction (SBO) is one of the most common causes of serious gastrointestinal disease in the US. Adhesion-related SBO (aSBO) is usually treated by the placement of a nasogastric tube (NGT) to decompress the stomach, administration of intravenous (IV) fluids and observation by a surgical team. The purpose of this feasibility study is to determine the potential for implementation of treatment protocols for aSBO and determine the feasibility of randomizing patients with aSBO to receive or not receive NGTs or water-soluble contrast (WSC). The investigators will also determine the ability to measure HRQOL as a main outcome for the treatment of aSBO. The studies outlined in this research program intend to address gaps in knowledge about how to determine who benefits from NGT placement, who can be managed without them, how to objectively determine when a bowel obstruction has resolved, how to reintroduce feeding to patients with aSBO, what criteria should be used for hospital discharge and what role cathartics such as WSC contrast have in the management of aSBO. This feasibility study will enroll a limited number of patients (n=40) who will be followed for up to 30 days.
Conditions Studied
Interventions
- DRUG Saline
- DRUG Gastrografin
- PROCEDURE SBO Treatment Without NG Tubes
Study Locations (1)
California
- University of California, Los Angeles, David Geffen School of Medicine - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2024-01-01 |
| Est. Completion | 2025-12-15 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06182319
The ClinicalTrials.gov registry entry for NCT06182319 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Adhesive Small Bowel Obstruction appearing as the primary indexed condition, and to 3 interventions - of which Saline is the first listed.
NCT06182319 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06182319 about?
NCT06182319 is a clinical study titled "Optimizing Treatment of Adhesive Small Bowel Obstruction". Small bowel obstruction (SBO) is one of the most common causes of serious gastrointestinal disease in the US. Adhesion-related SBO (aSBO) is usually treated by the placement of a nasogastric tube (NGT) to decompress the stomach, administration of intravenous (IV) fluids and observation by a surgical...
What is the current status of trial NCT06182319?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 40 participants. The study started on 2024-01-01. Estimated completion is 2025-12-15.
What conditions does trial NCT06182319 study?
This clinical trial studies the following conditions: Adhesive Small Bowel Obstruction.
What interventions are being tested in trial NCT06182319?
The interventions under investigation include: Saline (DRUG), Gastrografin (DRUG), SBO Treatment Without NG Tubes (PROCEDURE).
Who is sponsoring clinical trial NCT06182319?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06182319 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Adhesive Small Bowel Obstruction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.